FDA Okays Dexcom G4 Platinum Continuous Glucose Monitoring System With Share

(RTTNews) - DexCom Inc. (DXCM) announced Monday that it has received U.S. Food and Drug Administration (FDA) approval for its Dexcom G4 Platinum Continuous Glucose Monitoring System with Share.

The Dexcom Share receiver uses a secure wireless connection via Bluetooth Low Energy (BLE) between a patient's receiver and an app on the patient's smartphone to transmit glucose information to apps on the mobile devices of up to five designated recipients, or "followers," without the need for a dedicated docking cradle. These followers can remotely monitor a patient's glucose information and receive alert notifications from almost anywhere, initially via their Apple iPhone or iPod touch and in the future on Android devices, giving them peace of mind and reassurance when they are apart. The "Share" and "Follower" apps will be available on the Apple App Store at no charge.

The company noted that the Share receiver is anticipated to ship to new patients in early March 2015.All patients who purchased a Share cradle will receive a free upgrade to the Share receiver. All purchasers of a G4 Platinum receiver from January 1, 2015, until the Share receiver is shipped, will receive a free upgrade to the Share receiver. There will be a low cost cash upgrade to the Share receiver for those patients who are still under warranty with their existing receiver. The Share receiver will be compatible with future generation Dexcom sensor systems.